Bizily Scott bought FDMT
September 1, 2026 · Form 4 insider transaction
Bizily Scott bought 584 shares of 4D Molecular Therapeutics, Inc. at $6.49 per share, a transaction worth $3.8K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
584
Price
$6.49
Total value
$3.8K
InsiderBizily Scott
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateSeptember 1, 2026
Filing dateSeptember 3, 2026
Shares owned after9,201
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on January 13, 2026.